Chart 2. Recommendations of the Faculty of Sexual and Reproductive Healthcare (FSRH) for the use of contraception during the COVID-19 pandemic.

Situation	Recommendation
Request to start contraception	Evaluate remotely – provide desogestrel POPs for 6 to 12 months
Use of medroxyprogesterone acetate (injectable)	Desogestrel POPs
4-year-old etonogestrel implant	No indication of face-to-face consultation for exchange after expiration date – with the exception of women who wish to become pregnant or have serious adverse effects
	Indicated aditional desogestrel POP
Use of 52mg SIU of Levonogestrel	POP for aditional use
5-year-old copper IUD	No indication of face-to-face consultation for exchange after expiration date – with the exception of women who wish to become pregnant, have signs of infection or have serious adverse effects
	Condom use and/or desogestrel POPs
POP is not indicated/appropriate	Complete remote evaluation of eligibility for a COC – AP and BMI accurate and self-referred
	Provide 6- to 12-month supply
	Ineligible patient for COC: injectable medroxyprogesterone, etonogestrel implant and IUD can be considered

Abbreviations: AP, arterial pressure; BMI, body mass index; COC, combined oral contraceptive; IUD, intrauterine device; IUS, intrauterine system; POP, progestogen-only pill.